Delivery Order SPE2DR25D1109-SPE2DR26FFF4S
Award Date 10/22/25
Potential Completion Date 10/23/25
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,155.66 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin used in diabetes management, representing a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,455.79 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product used in diabetes treatment and represents part of the agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $2,003.37 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/ML vials (10 mL) on October 22, 2025, with completion scheduled for October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product used in diabetes management, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $2,020.06 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 14, 2025, with completion expected by July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. NovoLog is a rapid-acting insulin analog used in diabetes management, representing the type of critical pharmaceutical...
- The Defense Logistics Agency awarded a $9,344.14 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 13, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin used in diabetes management, representing part of the broader pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $10,835.94 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,296.60 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product commonly used in military and federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,761.74 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL units). This non-set-aside, firm fixed-price contract represents a single delivery order with an ultimate completion date of September 3, 2025. The award was issued on September 2, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product...
- The Defense Logistics Agency awarded a $2,145.94 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of NovoLog 100 Unit/ML vials (10 ML units). This is a firm fixed-price, non-set-aside contract with a completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product used in diabetes management and represents a critical pharmaceutical commodity within the...
- The Defense Logistics Agency awarded a delivery order valued at $4,654.66 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The...